Condition
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ clinical trials and research
Research outlook What's coming for Bladder cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 3 Non-muscle Invasive Bladder Cancer With Carcinoma in Situ clinical trials that are recruiting, at sites in 14 countries (most in United States (3), Canada (2), France (2)). By phase: Phase 3 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 14Countries
Newest Non-muscle Invasive Bladder Cancer With Carcinoma in Situ clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| TARA-002 vs chemotherapy for high-grade non-muscle invasive bladder cancer in adults not previously treated with BCG | Phase 3 | Queen Creek, Arizona and 10 other locations | Recruiting | Mar 18, 2026 |
| Evaluating a new treatment for high-grade bladder cancer | Phase 3 | Tucson, Arizona and 80 other locations | Recruiting | Aug 9, 2024 |
| EG-70 treatment for patients with high-risk non-muscle invasive bladder cancer | Phase 1/2 | Birmingham, Alabama and 101 other locations | Recruiting | Feb 12, 2021 |
All recruiting trials (3)
-
TARA-002 vs chemotherapy for high-grade non-muscle invasive bladder cancer in adults not previously treated with BCG
A phase 3 study tests whether TARA-002 can help adults with high-grade non-muscle invasive bladder cancer who haven’t had BCG, comparing it to standard intravesical chemotherapy.
-
Evaluating a new treatment for high-grade bladder cancer
This study is testing a new treatment for people with high-grade bladder cancer that hasn't responded to previous therapy to see if it can help them get better.
-
EG-70 treatment for patients with high-risk non-muscle invasive bladder cancer
This study is testing a new gene therapy called EG-70 to see if it can help patients with high-risk bladder cancer who haven't responded to or haven't received standard treatment.
Related topics
Quick answers
How many Non-muscle Invasive Bladder Cancer With Carcinoma in Situ clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (3 trials), Canada (2 trials), France (2 trials), South Korea (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.